Article
Molecular analysis of a public cross-neutralizing antibody response to SARS-CoV-2
2022-05-18
Abstract excerpt
<h4>ABSTRACT</h4> As SARS-CoV-2 variants of concerns (VOCs) continue to emerge, cross-neutralizing antibody responses become key towards next-generation design of a more universal COVID-19 vaccine. By analyzing published data from the literature, we report here that the combination of germline genes IGHV2-5/IGLV2-14 represents a public antibody response to the receptor-binding domain (RBD) that potently cross-neu...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e3caee53-0bc3-5d8a-9c2b-cf22e7baca8d
- DOI
- 10.1101/2022.05.17.492220
